It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TRAM2. The page also collects GeneMedi’s different modalities and formats products for TRAM2 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TRAM2 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Introcelluar Protein.
TRAM2 is a component of the translocon, a gated macromolecular channel that controls the posttranslational processing of nascent secretory and membrane proteins at the endoplasmic reticulum (ER) membrane.[supplied by OMIM, Jul 2004]